Variant report
Variant | esv2763491 |
---|---|
Chromosome Location | chr5:116211296-116229315 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6859942 | chr5:116211296-116211297 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs189037695 | chr5:116211299-116211300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs372096749 | chr5:116211347-116211348 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553894395 | chr5:116211350-116211351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10040444 | chr5:116211352-116211353 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs529810666 | chr5:116211411-116211412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs375146667 | chr5:116211477-116211478 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549495662 | chr5:116211480-116211481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192429775 | chr5:116211530-116211531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565736826 | chr5:116211532-116211533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532611571 | chr5:116211538-116211539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184406002 | chr5:116211574-116211575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35511410 | chr5:116211587-116211588 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs149289916 | chr5:116211615-116211616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs370600524 | chr5:116211616-116211617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565363349 | chr5:116211618-116211619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs377264755 | chr5:116211621-116211622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566367218 | chr5:116211625-116211626 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs534967417 | chr5:116211626-116211627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs554964586 | chr5:116211627-116211628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568334162 | chr5:116211628-116211629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs35171847 | chr5:116211641-116211642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs537419116 | chr5:116211662-116211663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557524371 | chr5:116211680-116211681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs201007845 | chr5:116211681-116211682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs370466156 | chr5:116211685-116211686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs116380306 | chr5:116211687-116211688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187509653 | chr5:116211691-116211692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs542069550 | chr5:116211694-116211695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572312376 | chr5:116211702-116211703 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs386691500 | chr5:116211710-116211711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs253891 | chr5:116211711-116211712 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs529677474 | chr5:116211718-116211719 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs562051249 | chr5:116211735-116211736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12188660 | chr5:116211771-116211772 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs532032724 | chr5:116211785-116211786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs552363687 | chr5:116211816-116211817 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs566108150 | chr5:116211826-116211827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140672454 | chr5:116211827-116211828 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs145766439 | chr5:116211881-116211882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs137936527 | chr5:116211899-116211900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537482488 | chr5:116211979-116211980 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557388270 | chr5:116211994-116211995 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs191794590 | chr5:116212019-116212020 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs374759473 | chr5:116212027-116212028 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368837937 | chr5:116212048-116212049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558730785 | chr5:116212082-116212083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572116643 | chr5:116212106-116212107 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540772425 | chr5:116212141-116212142 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs184008955 | chr5:116212198-116212199 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:116206000-116215600 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
2 | chr5:116209200-116211800 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
3 | chr5:116211800-116212200 | Enhancers | HSMM | muscle |
4 | chr5:116211800-116213200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr5:116214200-116217200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
6 | chr5:116215600-116216200 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |
7 | chr5:116216000-116216600 | Enhancers | Brain Germinal Matrix | brain |
8 | chr5:116216200-116224800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
9 | chr5:116217200-116218600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr5:116217800-116218200 | Enhancers | HepG2 | liver |
11 | chr5:116218000-116222600 | Enhancers | GM12878-XiMat | blood |
12 | chr5:116223600-116224200 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr5:116224800-116225200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
14 | chr5:116224800-116225400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:116224800-116225400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr5:116225200-116231800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
17 | chr5:116225400-116233800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
18 | chr5:116228600-116229200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
19 | chr5:116229200-116231600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |